Related Experiment Video
Updated: Mar 3, 2026

06:48
CRISPR Guide RNA Cloning for Mammalian Systems
Published on: October 2, 2018
73.2K
Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Daan C Swarts1, John van der Oost2, Martin Jinek1
1Department of Biochemistry, University of Zurich, CH-8057 Zurich, Switzerland.
Molecular Cell
|April 22, 2017
Summary
The CRISPR-Cas12a (Cpf1) enzyme has two nuclease activities crucial for genome editing. Structural studies reveal how Cas12a processes guide RNAs and cleaves target DNA, advancing gene editing technology.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- CRISPR-associated protein Cas12a (Cpf1) is a versatile tool in genome editing.
- Cas12a exhibits distinct endoribonuclease and RNA-guided DNase activities.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying Cas12a's dual nuclease activities.
- To understand guide RNA processing and target DNA binding/cleavage.
Main Methods:
- Determined crystal structures of Francisella novicida Cas12a.
- Complex structures included guide RNA and target DNA R-loops.
- Biochemical experiments corroborated structural findings.
Main Results:
- Revealed mechanisms for guide RNA processing and pre-ordering for target binding.
- Identified a strand displacement mechanism for guide-target hybridization.
- Suggested a single active site mechanism for double-stranded DNA cleavage.
Conclusions:
- Provided detailed molecular insights into Cas12a enzyme function.
- These findings may facilitate the further development of CRISPR-Cas12a genome editing technologies.
Related Concept Videos
CRISPR
58.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.4K
CRISPR/Cas9 Genome Editing
2.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.2K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
The Antiviral System of Bacteria and Archaea: CRISPR
843
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
843
RNA Interference
28.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K
Homologous Recombination
64.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.4K

